Epigenomics to Meet with FDA, Hire US Head as it Looks to Crack US Market | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – As Epigenomics prepares to enter the US market, it plans to meet with the US Food and Drug Administration in the coming weeks and to hire someone to direct its commercial operations in the US.

On the sidelines of the JP Morgan Healthcare Conference last week in San Francisco, an official from the German molecular diagnostics firm outlined the company's plan to break into the US market with its lead product, the Epi proColon test for the early detection of colon cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.